Corcept Therapeutics Inc

Ownership Transactions Reported by 15 Insiders

Symbol
CORT on Nasdaq
Location
101 Redwood Shores Parkway, Redwood City, CA

Insiders trading volume in the past year

Corcept Therapeutics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
G. Leonard Baker Jr Director $316M Jun 10, 2025
Joseph K. Belanoff Chief Executive Officer, Director $208M -$21.9M -9.51% Dec 1, 2025
James N. Wilson Director $138M Jun 10, 2025
David Mahoney Director $92.2M -$2.03M -2.16% Jun 10, 2025
Hazel Hunt Chief Scientific Officer $12.5M Feb 28, 2025
Gary Charles Robb Chief Business Officer $2M -$1.12M -35.9% Dec 1, 2025
Sean Maduck Officer $1.42M -$25.4M -94.7% Dec 1, 2025
Atabak Mokari Chief Financial Officer $1.01M Dec 1, 2025
Joseph Douglas Lyon Chief Accounting & Technology Officer $757K -$24M -96.9% Dec 1, 2025
Gillian Cannon Director $518K Sep 10, 2025
William Guyer Chief Development Officer $63.7K -$13.6M -99.5% Dec 1, 2025
Daniel N. Swisher JR Director $0 -$1.65M -100% Oct 10, 2025
Gregg H. Alton Director Jun 10, 2025
Kimberly Park Director Jun 10, 2025
Joshua M. Murray Director Jun 10, 2025

Recent Insider Transactions by Companies or Individuals for Corcept Therapeutics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.